FDA approves Abbott's next-gen spinal cord stimulation therapy
Abbott announced today that the FDA approved its new Proclaim Plus spinal cord stimulation (SCS) system with FlexBurst360.
Source: massdevice.com
Stay updated with breaking news from Proclaim Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott announced today that the FDA approved its new Proclaim Plus spinal cord stimulation (SCS) system with FlexBurst360.
News and commentary from the world of neurology and neuroscience